Clinical Trial

Psilocybin-Assisted Therapy

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This pilot study will examine the safety, tolerability, acceptability, and efficacy of combination psilocybin + psychotherapy to decrease PTSD symptoms. Participants will be randomized into two different treatment groups, allowing the investigators to directly compare PE augmented with psilocybin and psilocybin-assisted psychotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-08; most recent amendment 2026-05-21.
Trial Details
NCT Number NCT07332143
Lead Sponsor Emory University
Collaborators: Georgia Department of Veterans Services
Conditions PTSD
Enrollment 150 participants
Start Date 2026-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-26